Controlling IL-7 injections in HIV-infected patients
From MaRDI portal
Publication:1990146
Abstract: Immune interventions consisting in repeated injection are broadly used as they are thought to improve the quantity and the quality of the immune response. However, they also raised several questions that remains unanswered, in particular the number of injections to make or the delay to respect between different injections to acheive this goal. Practical and financial considerations add constraints to these questions, especially in the framework of human studies. We specifically focus here on the use of interleukine-7 (IL-7) injections in HIV-infected patients under antiretroviral treatment, but still unable to restore normal levels of CD4+ T lymphocytes. Clinical trials have already shown that repeated cycles of injections of IL-7 could help maintaining CD4+ T lymphocytes levels over the limit of 500 cells per microL, by affecting proliferation and survival of CD4+ T cells. We then aim at answering the question : how to maintain a patient's level of CD4+ T lymphocytes by using a minimum number of injections (ie optimizing the strategy of injections) ? Based on mechanistic models that were previously developed for the dynamics of CD4+ T lymphocytes in this context, we model the process by a piecewise deterministic Markov model. We then address the question by using some recently established theory on impulse control problem in order to develop a numerical tool determining the optimal strategy. Results are obtained on a reduced model, as a proof of concept : the method allows to defined an optimal strategy for a given patient. This method could applied to optimize injections schedules in clinical trials.
Recommendations
- Modeling CD4\(^+\) T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
- Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection
- Immunotherapy of HIV-1 infection
- A controlled treatment strategy applied to HIV immunology model
- An optimal control strategy for antiretroviral treatment of HIV infection in presence of immunotherapy
- Immuno-modulatory strategies for reduction of HIV reservoir cells
- Control of HIV Infection Dynamics
- Modeling interleukin-2-based immunotherapy in AIDS pathogenesis
- FEEDBACK CONTROL OF THE CHEMOTHERAPY OF HIV
- Optimization of interleukin-21 immunotherapeutic strategies
Cites work
- scientific article; zbMATH DE number 3901778 (Why is no real title available?)
- Cancer immunotherapy, mathematical modeling and optimal control
- Constrained and unconstrained optimal discounted control of piecewise deterministic Markov processes
- Determination of the optimal therapeutic protocols in cancer immunotherapy
- Mathematical models for immunology: current state of the art and future research directions
- Modeling CD4\(^+\) T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
Cited in
(3)- Evaluating the use of generalized dynamic weighted ordinary least squares for individualized HIV treatment strategies
- Modeling CD4\(^+\) T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7
- On ``Reflections on the concept of optimality of single decision point treatment regimes
This page was built for publication: Controlling IL-7 injections in HIV-infected patients
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1990146)
